...
首页> 外文期刊>Journal of Veterinary Pharmacology and Therapeutics >Pharmacokinetics of toltrazuril and its metabolites in pregnant and nonpregnant ewes and determination of their concentrations in milk, allantoic fluid, and newborn plasma
【24h】

Pharmacokinetics of toltrazuril and its metabolites in pregnant and nonpregnant ewes and determination of their concentrations in milk, allantoic fluid, and newborn plasma

机译:托洛拉洛尔的药代动力学及其在孕妇和非妊娠母羊中的代谢产物和牛奶,腺体液和新生血浆中浓度的测定

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The objectives of this study were to determine the pharmacokinetics of toltrazuril and its metabolites in pregnant and nonpregnant ewes following a single oral dose and to determine the plasma concentrations of these compounds in milk, allantoic fluid, and newborn plasma. Eighteen healthy ewes were randomly divided into three groups (n = 6 each): pregnant ewes at 12-13 weeks of gestation (group A), nonpregnant ewes (group B), and pregnant ewes at 1-2 weeks before expected lambing date (group C). Ewes in all groups received a single oral dose of toltrazuril at 20 mg/kg body weight. In groups A and B, blood samples were collected at 1, 3, 5, 7, 9, 12, 15, 18 hr, every 6 hr to day 3, every 12 hr to day 7 and thereafter every 24 hr to day 14 post-toltrazuril administration. In group C, parturition was induced 24-36 hr after toltrazuril administration then milk, allantoic fluid, and newborn plasma samples were collected immediately after birth. Drug metabolites were assayed using ultra high-performance liquid chromatography-ultraviolet detection method (UHPLC-UV). The maximum concentration (C-max), area under the plasma concentration-time curve (AUC(0-t)), AUC to 24 and 48 hr (AUC(0-24)), and (AUC(0-48)) were significantly higher in pregnant ewes. Longer apparent half-life (T-1/2), significantly higher apparent volume of distribution (Vd/F) and total clearance (Cl/F) were observed in nonpregnant ewes. The time to maximum plasma concentration (T-max), mean residence time (MRT) and elimination rate constant (K-el) were similar in both groups. The AUC(0-24) and AUC(0-48) were significantly higher in nonpregnant ewes. The AUC(0-t) was significantly higher in pregnant ones. The ratio of plasma toltrazuril concentrations in ewes and toltrazuril concentrations in newborn lambs' plasma, allantoic fluid, and milk were 68%, 2.3%, and 5.3%, respectively. Results of this study showed that toltrazuril is well absorbed after a single oral dose in ewes with widespread distribution in different body tissues.
机译:本研究的目的是在单个口服剂量之后确定妊娠和非妊娠EWES中耐药素和其代谢物的药代动力学,并确定这些化合物在牛奶,腺体液和新生等离子体中的血浆浓度。将十八个健康的母羊随机分为三组(n = 6各自):怀孕的母羊在妊娠12-13周的妊娠(A组),非妊娠母羊(B),并在预期的罕有日期前1-2周怀孕母羊( C组)。所有组中的母羊都接受了20mg / kg体重的单一口服剂量耐药素。在A组和B组中,每6小时至第3天,每隔6小时至第3天,每隔12小时,每隔24小时,每隔24小时,每隔12小时,每隔24小时,每隔6天,每隔24小时,就收集血样。 -tolrazuril管理。在C组中,在出生后立即收集耐可牛奶,腺体液和新生儿样品后24-36小时诱导分娩。使用超高效液相色谱 - 紫外检测方法(UHPLC-UV)测定药物代谢物。血浆浓度 - 时间曲线(AUC(0-T)),AUC至24和48小时(AUC(0-24))和(AUC(0-48))下的最大浓度(C-MAX),AUT怀孕的母羊在孕产量显着高。在非妊娠母羊中观察到较长的半衰期(T-1/2),显着较高的分布(VD / F)和总间隙(Cl / F)。两组中,最大血浆浓度(T-MAX),平均停留时间(MRT)和消除率常数(K-EL)的时间相似。 AUC(0-24)和AUC(0-48)在非妊娠母羊中显着高。 AUC(0-T)在怀孕的AUC(0-T)显着高。新生羊羔等离子体,甲状腺液和牛奶中EWES和耐药素浓度的血浆耐药素浓度的比例分别为68%,2.3%和5.3%。该研究的结果表明,在母羊在母羊的单个口服剂量后,耐者溶质溶解度很好地吸收,不同的身体组织中的普遍分布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号